title: Eruptive keratoacanthomas as a complication of fractionated CO2 laser resurfacing and combination therapy with imiquimod and intralesional methotrexate.
authors.affiliation: Department of Dermatology, Loma Linda University, Loma Linda, California St. Joseph Heritage Medical Group Orange, California Loma Linda Dermatology Medical Group Loma Linda, California.
authors.forename: David
authors.initials: D
authors.lastname: Panther
authors.forename: Tanya
authors.initials: T
authors.lastname: Nino
authors.forename: K Dale
authors.initials: KD
authors.lastname: Macknet
authors.forename: Cathy
authors.initials: C
authors.lastname: Macknet
mesh_terms: D000279:Administration, Cutaneous; D000368:Aged; D000634:Aminoquinolines / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D000077271:Imiquimod; D015552:Injections, Intralesional; D007636:Keratoacanthoma / Q000188:drug therapy* / Q000209:etiology; D054020:Lasers, Gas / Q000009:adverse effects; D008727:Methotrexate / Q000008:administration & dosage; D012060:Rejuvenation; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000209:etiology
chemical_list: D000634:Aminoquinolines; D000077271:Imiquimod; D008727:Methotrexate